A Bold Prescription for Higher Education
When Jerry Balentine, D.O., assumed the presidency of New York Tech on July 1, he stepped into a role he never envisioned for himself as a young physician in the Bronx.

Trained as an emergency medicine specialist, Balentine planned for a career treating patients, training residents, and thriving in the unpredictable world of the emergency department.
Now, as the university’s fifth president, Balentine is drawing on his background in emergency medicine, health system administration, and academic leadership to guide New York Tech through one of higher education’s most challenging eras.
This article originally appeared in the fall 2025/winter 2026 issue of New York Institute of Technology Magazine.
By Renée Gearhart Levy
More News
The Cassowary’s Impact on the Rainforest
NYITCOM-Arkansas Assistant Professor Todd Green, Ph.D., sheds light on a bird species that plays an impactful role in rainforest conservation.
Big Investments in Student Entrepreneurs
New York Tech’s new Innovation and Entrepreneurship Academy supports the success of student entrepreneurs.
FRIENDS Sets New Fundraising Record
On October 30, the School of Architecture and Design celebrated its 17th Annual Alumni and FRIENDS Reception, raising a record-breaking $556,000 in support of student scholarships, technology upgrades, lectures, study abroad, and new initiatives.
Student Veteran Spotlight: Dru Arana
Dru Arana joined the U.S. Navy to get field experience in construction and civil engineering. After a successful career, he decided to pursue a lateral shift into energy and sustainability engineering, enrolling in the College of Engineering and Computing Sciences.
Intern Insight: Madalina Cupsa
Bioengineering student Madalina Cupsa began interning at The Mount Sinai Hospital in January and is now approaching one year as a research assistant.
Engineering a Cancer Treatment Game Changer
A groundbreaking project co-led by the College of Engineering and Computing Sciences’ Steven Zanganeh, Ph.D., provides the world’s first functional, drug-testable, 3-D-printed human colon model.